IRIS Institutional Research Information System - OPENBS Open Archive UniBS

QUIROS ROLDAN, Maria Eugenia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.566
EU - Europa 6.159
AS - Asia 4.494
OC - Oceania 28
AF - Africa 27
Continente sconosciuto - Info sul continente non disponibili 14
SA - Sud America 14
Totale 26.302
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.522
CN - Cina 2.055
UA - Ucraina 1.730
SG - Singapore 1.126
DE - Germania 1.040
IT - Italia 801
HK - Hong Kong 626
PL - Polonia 605
FI - Finlandia 507
RU - Federazione Russa 390
GB - Regno Unito 367
IE - Irlanda 360
TR - Turchia 352
IN - India 192
FR - Francia 139
SE - Svezia 73
CA - Canada 36
CZ - Repubblica Ceca 35
ID - Indonesia 34
BE - Belgio 32
VN - Vietnam 32
AU - Australia 27
IR - Iran 27
NL - Olanda 27
EU - Europa 14
JP - Giappone 14
MU - Mauritius 10
AT - Austria 9
RO - Romania 9
ES - Italia 7
KR - Corea 6
BR - Brasile 5
SA - Arabia Saudita 5
AR - Argentina 4
HU - Ungheria 4
IL - Israele 4
LT - Lituania 4
MK - Macedonia 4
MX - Messico 4
UG - Uganda 4
BD - Bangladesh 3
CI - Costa d'Avorio 3
EE - Estonia 3
EG - Egitto 3
PK - Pakistan 3
CH - Svizzera 2
CL - Cile 2
CM - Camerun 2
CR - Costa Rica 2
ET - Etiopia 2
KZ - Kazakistan 2
PE - Perù 2
PH - Filippine 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EC - Ecuador 1
GE - Georgia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 26.302
Salva come PNG Salva come JPEG
Città #
Fairfield 2.269
Woodbridge 1.906
Jacksonville 1.333
Houston 1.234
Ashburn 1.158
Singapore 938
Seattle 929
Cambridge 918
Wilmington 878
Ann Arbor 839
Chandler 730
Princeton 636
Hong Kong 625
Warsaw 604
Nanjing 466
Dublin 354
Istanbul 308
Helsinki 307
New York 276
Beijing 229
Nanchang 189
Dearborn 183
Moscow 177
Brescia 155
Des Moines 151
San Diego 138
Shenyang 127
Hebei 124
Shanghai 116
Changsha 115
Jinan 110
Milan 101
Lancaster 93
Tianjin 85
Jiaxing 65
Kunming 59
Hangzhou 52
London 50
Los Angeles 44
Munich 42
Ningbo 38
Verona 37
Zhengzhou 34
Jakarta 32
Brno 31
San Francisco 31
Brussels 30
Dong Ket 30
Boardman 29
Kocaeli 29
Romola 29
Taizhou 29
Leawood 26
Toronto 26
Guangzhou 25
Washington 25
Ardabil 24
Lanzhou 24
San Mateo 24
Haikou 20
Orange 19
Taiyuan 19
Falkenstein 17
Frankfurt am Main 17
Melbourne 15
Augusta 14
Kilburn 14
Norwalk 14
Fuzhou 13
Monmouth Junction 12
Changchun 11
Hefei 11
Nürnberg 11
Pune 11
Rome 11
Tokyo 11
Chicago 10
Lappeenranta 10
Bergamo 9
Gorle 9
Hanover 9
Napoli 9
Chiswick 8
Nuremberg 7
Santa Clara 7
Canberra 6
Florence 6
Islington 6
Prescot 6
Rende 6
Monza 5
Mountain View 5
New Bedfont 5
Phoenix 5
Redwood City 5
Torino 5
Wandsworth 5
Acton 4
Auburn Hills 4
Espoo 4
Totale 20.061
Salva come PNG Salva come JPEG
Nome #
The impact of antiretroviral therapy on iron homeostasis and inflammation markers in HIV-infected patients with mild anemia 237
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 237
Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study 218
Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA 208
Modulation of Regulatory T-cell Subsets in Very Long-term Treated Aviremic HIV(+) Patients and Untreated Viremic patients 201
Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment 168
Burden of Non-AIDS-Defining and Non-Virus-Related Cancers Among HIV-Infected Patients in the Combined Antiretroviral Therapy Era. 161
Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study 161
Hepatitis C infection influence on immune recovery in HIV-positive patients on successful HAART: The role of genotype 3 160
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 158
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 150
Antiretroviral therapy in geriatric HIV patients: the GEPPO cohort study 150
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 148
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 142
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 142
Prevalence of integrase strand transfer inhibitors (InSTIs) resistance mutations in InSTIs-naive and -experienced HIV-1 infected patients: a single Center experience 141
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 141
Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. 140
Cryptogenic liver diseases: sailing by sight from HIV co-infection with hepatitis viruses to HIV mono-infection through the Pillars of Hercules. 137
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study 137
Evidence for antigenic selection of large granular lymphocytes in a patient with Wiskott-Aldrich syndrome 136
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 135
Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy 133
HIV-associated asymmetric lipodystrophy syndrome 128
Incidence of cardiovascular events in HIV-positive patients compared to general population over the last decade: a population-based study from 2000 to 2012 128
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 127
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 125
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 125
Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone 124
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 124
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 124
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 123
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study 123
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 123
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment 122
Breast cancer among human immunodeficiency virus (HIV)-infected patients: the experience in Brescia, Northern Italy. 118
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 116
Prevalence of non-B HIV-1 subtypes in North Italy and analysis of transmission clusters based on sequence data analysis 116
An enzyme-linked (alkaline phosphatase) oligonucleotide probe for the detection of serum hepatitis B virus DNA. 115
Lung cancer in HIV-infected patients: the experience in Brescia from 1999 to 2009 115
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 114
Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month 114
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 114
Neutrophil to Lymphocyte Ratio and Cardiovascular Disease Incidence in HIV-Infected Patients: A Population-Based Cohort Study 113
Timed short messaging service improves adherence and virological outcomes in HIV-1-infected patients with suboptimal adherence to antiretroviral therapy 113
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients 112
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 111
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 110
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 110
Consequences of the COVID-19 pandemic on the continuum of care in a cohort of people living with HIV followed in a single center of Northern Italy 110
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 109
Modifications in SENV DNA detection and/or SENV subtype determination over a prospective follow-up in a cohort of HIV-positive patients: is this a moving target? 108
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of northern Italy,1999-2009 108
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir containing regimens 107
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 107
Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus 107
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort 107
The burden of chronic diseases and cost-of-care in subjects with HIV infection in a Health District of Northern Italy over a 12-year period compared to that of the general population 107
Immune complex p24 antigen: a new prognostic marker in human immunodeficiency virus infection 106
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 106
Systemic Inflammation-Based Biomarkers and Survival in HIV-Positive Subject with Solid Cancer in an Italian Multicenter Study 105
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 105
Immune response in children with COVID-19 is characterized by lower levels of T-cell activation than infected adults 105
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide 104
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 104
Mortality for liver disease in patients with HIV infection: a cohort study 104
Different TCRBV genes generate biased patterns of V-D-J diversity in human T cells 104
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV 104
Low-level viraemia, measured as viraemia copy-years, as a prognostic factor for medium-long-term all-cause mortality: A MASTER cohort study 104
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. 103
Polymorphic immune restoration syndrome after effective HAART 103
Impact of detectable human cytomegalovirus DNAemia on viro-immunologicaleffectiveness of HAART in HIV-infected patients naive to antiretroviral therapy 103
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) 103
Increased risk of virological failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort 103
Serum hepatitis B virus DNA detection with S- and C-region-directed probes 102
An outbreak of Serratia marcescens bloodstream infections associated with misuse of drug vials in a surgical ward 102
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 102
Comparison between the gold standard DXA with calcaneal quantitative ultrasound based-strategy (QUS) to detect osteoporosis in an HIV infected cohort 102
The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study 102
Helicobacter pylori seroepidemiology in risk groups 101
Detection of clonal T cell populations with closely related T cell receptor junctional sequences in persons at high risk for human immunodeficiency virus (HIV) infection and in patients acutely infected with HIV 101
Construction of a superantigen through a structural modification of an inactive protein 100
CD4+ T cell evolution and predictors of its trend before and aftertenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load 100
The impact of integrase inhibitor-based regimens on markers of inflammation among HIV naïve patients 100
Lymphocyte homeostasis is maintained in perinatally HIV-infected patients after three decades of life 100
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48 week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial 99
Risk factors for myocardial infarction in HIV positive patients 99
Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: A prospective international cohort study 99
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 99
Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy. 99
Disseminated Histoplasmosis as AIDS-presentation. Case Report and Comprehensive Review of Current Literature 99
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 98
Peripheral loss of regulatory T cells and polyautoimmunity in an HIV-infected patient 98
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 98
First Italian Consensus Statement on Diagnosis, Prevention and Treatment of Cardiovascular Complications in HIV-infected Patients in the HAART Era (2006). 97
Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy). 97
Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir 97
Projections of non-communicable disease and health care costs among HIV-positive persons in Italy and the U.S.A.: A modelling study 97
Diagnosis of HIV-1 infection by PCR with two primer pairs 96
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients 96
Totale 12.044
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.062
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.062
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.205 0 0 0 0 0 0 627 692 467 887 159 373
2020/20214.749 87 538 259 665 251 529 171 523 548 479 507 192
2021/20222.521 174 390 75 149 37 134 155 183 128 299 208 589
2022/20232.343 355 69 46 152 185 636 10 227 381 38 112 132
2023/20242.504 130 72 225 196 107 423 78 108 650 30 70 415
2024/20252.384 81 45 74 788 752 644 0 0 0 0 0 0
Totale 26.869